SensoDetect specialises in the development of equipment used to analyse the reaction of sound stimulus in the brain of a patient. The technology is mainly used in psychiatry when treating patients to distinguish potential mental disorders. The product consists of electrodes that are attached to the head of the patient to analyse brain activity. The results are compared against a database for further analysis. SensoDetect was founded in 2005 and is based in Lund.

Quotes for SensoDetect AB

Right Now

+/-
-0.016
%
-3,09%
Latest
0.502
High
0.52
Low
0.5
Volume
29 130
Turnover (SEK)
14 691
Value (MSEK)
30,0

Board

CEO

  • Martin Linde

Chairman Of The Board

  • Per-Ola Rosenqvist

Board

  • Anders Wallseth
  • Haqvin Svensson
  • Johan Granath
  • Sören Nielzén

Videos